1. Home
  2. ORGO vs AIRS Comparison

ORGO vs AIRS Comparison

Compare ORGO & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

SELL

Current Price

$1.16

Market Cap

166.0M

Sector

Health Care

ML Signal

SELL

Logo AirSculpt Technologies Inc.

AIRS

AirSculpt Technologies Inc.

SELL

Current Price

$1.48

Market Cap

182.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ORGO
AIRS
Founded
1985
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
166.0M
182.4M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
ORGO
AIRS
Price
$1.16
$1.48
Analyst Decision
Hold
Hold
Analyst Count
2
3
Target Price
$2.00
★ $4.50
AVG Volume (30 Days)
593.3K
★ 853.8K
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1600.00
N/A
EPS
N/A
★ N/A
Revenue
★ $564,169,000.00
$151,818,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$37.55
$2.65
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 17.04
N/A
52 Week Low
$1.20
$1.51
52 Week High
$7.08
$12.00

Technical Indicators

Market Signals
Indicator
ORGO
AIRS
Relative Strength Index (RSI) 24.68 26.88
Support Level N/A N/A
Resistance Level $2.69 $2.03
Average True Range (ATR) 0.06 0.13
MACD -0.00 0.01
Stochastic Oscillator 1.73 0.00

Price Performance

Historical Comparison
ORGO
AIRS

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

Share on Social Networks: